Correlation Between Shuttle Pharmaceuticals and Spruce Biosciences
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and Spruce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and Spruce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and Spruce Biosciences, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and Spruce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of Spruce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and Spruce Biosciences.
Diversification Opportunities for Shuttle Pharmaceuticals and Spruce Biosciences
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Shuttle and Spruce is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and Spruce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spruce Biosciences and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with Spruce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spruce Biosciences has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and Spruce Biosciences go up and down completely randomly.
Pair Corralation between Shuttle Pharmaceuticals and Spruce Biosciences
Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to generate 1.65 times more return on investment than Spruce Biosciences. However, Shuttle Pharmaceuticals is 1.65 times more volatile than Spruce Biosciences. It trades about -0.02 of its potential returns per unit of risk. Spruce Biosciences is currently generating about -0.14 per unit of risk. If you would invest 125.00 in Shuttle Pharmaceuticals on October 25, 2024 and sell it today you would lose (26.90) from holding Shuttle Pharmaceuticals or give up 21.52% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Shuttle Pharmaceuticals vs. Spruce Biosciences
Performance |
Timeline |
Shuttle Pharmaceuticals |
Spruce Biosciences |
Shuttle Pharmaceuticals and Spruce Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Shuttle Pharmaceuticals and Spruce Biosciences
The main advantage of trading using opposite Shuttle Pharmaceuticals and Spruce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, Spruce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spruce Biosciences will offset losses from the drop in Spruce Biosciences' long position.Shuttle Pharmaceuticals vs. Lifecore Biomedical | Shuttle Pharmaceuticals vs. Tilray Inc | Shuttle Pharmaceuticals vs. Organogenesis Holdings | Shuttle Pharmaceuticals vs. Journey Medical Corp |
Spruce Biosciences vs. Inozyme Pharma | Spruce Biosciences vs. Day One Biopharmaceuticals | Spruce Biosciences vs. Terns Pharmaceuticals | Spruce Biosciences vs. Eledon Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
CEOs Directory Screen CEOs from public companies around the world |